Published in J Gerontol on January 01, 1966
Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity (2000) 10.34
Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature (2000) 7.15
Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc Natl Acad Sci U S A (1996) 6.04
p140mDia, a mammalian homolog of Drosophila diaphanous, is a target protein for Rho small GTPase and is a ligand for profilin. EMBO J (1997) 5.03
STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J (1999) 4.55
A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell (1994) 4.35
Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest (1991) 3.70
Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells (1999) 3.69
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation (1994) 3.63
ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett (1996) 3.46
T-786-->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation (1999) 3.41
Cardiovascular anomaly, impaired actin bundling and resistance to Src-induced transformation in mice lacking p130Cas. Nat Genet (1998) 3.38
Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med (1997) 3.35
Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab (2001) 3.16
Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int (2007) 2.93
Congenital Cyst of the Myocardium. Am J Pathol (1945) 2.89
Spontaneous Cerebellar Hemorrhage: Report of Fifteen Cases. Am J Pathol (1942) 2.77
Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells (1997) 2.72
Rac1 is required for the formation of three germ layers during gastrulation. Oncogene (1998) 2.61
Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc Natl Acad Sci U S A (2000) 2.58
K-ras is essential for the development of the mouse embryo. Oncogene (1997) 2.57
Expression of the Fas ligand in cells of T cell lineage. J Immunol (1995) 2.54
Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab (2000) 2.43
Murine homolog of SALL1 is essential for ureteric bud invasion in kidney development. Development (2001) 2.42
Takayasu's arteritis. Clinical report of eighty-four cases and immunological studies of seven cases. Circulation (1967) 2.42
Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension (1996) 2.37
Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice. Kidney Int (2007) 2.21
Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. J Clin Invest (1995) 2.15
mGluR1 in cerebellar Purkinje cells essential for long-term depression, synapse elimination, and motor coordination. Science (2000) 2.09
Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation (1996) 2.06
Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology (1992) 2.06
Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation (1993) 2.04
Transillumination-assisted orotracheal intubation: a comparison of the Bonfils fibrescope and the lightwand (Trachlight). Acta Anaesthesiol Scand (2012) 2.02
Serum leptin level is a regulator of bone mass. Proc Natl Acad Sci U S A (2004) 1.99
Dwarfism and early death in mice lacking C-type natriuretic peptide. Proc Natl Acad Sci U S A (2001) 1.99
Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes (2001) 1.94
Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation (1999) 1.90
Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension (1998) 1.88
Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation (1991) 1.87
Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation (1993) 1.82
Impairment of hippocampal mossy fiber LTD in mice lacking mGluR2. Science (1996) 1.81
Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system". J Clin Invest (1992) 1.78
Targeted deletion of the H-ras gene decreases tumor formation in mouse skin carcinogenesis. Oncogene (2000) 1.76
Glucocorticoid regulation of leptin synthesis and secretion in humans: elevated plasma leptin levels in Cushing's syndrome. J Clin Endocrinol Metab (1997) 1.76
Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation (1998) 1.69
Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart. J Clin Invest (1989) 1.69
Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest (2000) 1.68
K channel activation by nucleotide diphosphates and its inhibition by glibenclamide in vascular smooth muscle cells. Br J Pharmacol (1993) 1.67
Inhibition of rho-associated kinase results in suppression of neointimal formation of balloon-injured arteries. Circulation (2000) 1.65
Studies of bacterial susceptibility of heart valves. Lab Invest (1968) 1.64
Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res (1994) 1.63
Ocular manifestations in patients infected with human T-lymphotropic virus type I. Jpn J Ophthalmol (1989) 1.63
Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene. J Clin Invest (1994) 1.60
A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet (1998) 1.59
Experimental endocarditis. Endocrine factors in valve lesions on AV shunt rats. Arch Pathol (1966) 1.59
Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function. Circulation (1987) 1.58
Activity of amino-laevulinic acid synthetase in normal and porphyric human livers. Nature (1966) 1.57
Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer (1995) 1.57
Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin. Diabetes (1999) 1.55
C-type natriuretic peptide (CNP) in rats and humans. Endocrinology (1991) 1.54
Refractory hepatic hydrothorax treated with transjugular intrahepatic portosystemic shunt. J Gastroenterol (1999) 1.54
Natriuretic peptide regulation of endochondral ossification. Evidence for possible roles of the C-type natriuretic peptide/guanylyl cyclase-B pathway. J Biol Chem (1998) 1.54
Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med (1990) 1.53
Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol (1998) 1.53
Effects of stimulation of the vagus nerve on insulin secretion. Endocrinology (1967) 1.53
Referral patterns to and from inpatient psychiatric services: a social network approach. Am J Public Health (1986) 1.52
Associations of various gene polymorphisms with toxicity in colorectal cancer patients receiving oral uracil and tegafur plus leucovorin: a prospective study. Ann Oncol (2010) 1.52
The neuron-restrictive silencer element-neuron-restrictive silencer factor system regulates basal and endothelin 1-inducible atrial natriuretic peptide gene expression in ventricular myocytes. Mol Cell Biol (2001) 1.51
Clinicopathological factors associated with clinical outcomes of endoscopic submucosal dissection for colorectal epithelial neoplasms. Endoscopy (2009) 1.51
Hereditary muscular atrophy with ataxia, retinitis pigmentosa, and diabetes mellitus. A clinical report of a family. Neurology (1968) 1.49
Spontaneous tumorigenesis in mice defective in the MTH1 gene encoding 8-oxo-dGTPase. Proc Natl Acad Sci U S A (2001) 1.48
Cloning of follistatin-related protein as a novel autoantigen in systemic rheumatic diseases. Int Immunol (1998) 1.48
Prevalence and characterization of hepatitis C virus in hemodialysis patients. Intern Med (1999) 1.45
Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: comparison in patients with hepatitis B virus- and hepatitis C virus-associated cirrhosis. J Gastroenterol Hepatol (1996) 1.45
Genetic models reveal that brain natriuretic peptide can signal through different tissue-specific receptor-mediated pathways. Endocrinology (2000) 1.45
Prostaglandin D2 in rat brain, spinal cord and pituitary: basal level and regional distribution. Life Sci (1982) 1.44
A 59-kilodalton protein associated with progestin, estrogen, androgen, and glucocorticoid receptors. Biochemistry (1986) 1.42
Lymphocytic infundibuloneurohypophysitis as a cause of central diabetes insipidus. N Engl J Med (1993) 1.41
Solitary squamous cell papilloma of the trachea. Ann Thorac Surg (1993) 1.40
Behavior of hepatic microsomal cytochromes after treatment of mice with drugs known to disturb porphyrin metabolism in liver. Biochem Pharmacol (1968) 1.40
Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes. Circulation (1997) 1.38
Toxic shock-like syndrome caused by T serotype B3264 streptococcus. Intern Med (2000) 1.38
Biochemical changes in the brain in rats poisoned with an alkymercury compound, with special reference to the inhibition of protein synthesis in brain cortex slices. J Neurochem (1966) 1.38
Correlation of residual stenosis immediately after coronary angioplasty with long-term prognosis. Cathet Cardiovasc Diagn (1998) 1.38
cGMP-dependent protein kinase phosphorylates and inactivates RhoA. Biochem Biophys Res Commun (2001) 1.37
The rck/p54 candidate proto-oncogene product is a 54-kilodalton D-E-A-D box protein differentially expressed in human and mouse tissues. Cancer Res (1995) 1.37
Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes. Diabetes (2001) 1.37
Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide. Proc Natl Acad Sci U S A (1998) 1.34
Increased plasma endothelin level in patients with essential hypertension. N Engl J Med (1990) 1.33
Augmented expression of atrial natriuretic polypeptide gene in ventricles of spontaneously hypertensive rats (SHR) and SHR-stroke prone. Circ Res (1988) 1.33
Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation. Circulation (1991) 1.32
The human endothelin-B receptor gene. Structural organization and chromosomal assignment. J Biol Chem (1993) 1.32
Lysophosphatidic acid induces tyrosine phosphorylation and activation of MAP-kinase and focal adhesion kinase in cultured Swiss 3T3 cells. FEBS Lett (1993) 1.31
Single channel and whole-cell K-currents evoked by levcromakalim in smooth muscle cells from the rabbit portal vein. Br J Pharmacol (1993) 1.31
Motor discoordination results from combined gene disruption of the NMDA receptor NR2A and NR2C subunits, but not from single disruption of the NR2A or NR2C subunit. J Neurosci (1996) 1.30
Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure. Br Heart J (1994) 1.30
Actions of cromakalim on ionic currents recorded from single smooth muscle cells of the rat portal vein. J Pharmacol Exp Ther (1990) 1.30
Alpha-human atrial natriuretic polypeptide is released from the heart and circulates in the body. Biochem Biophys Res Commun (1985) 1.30